Browsing Tag
CVS Caremark
3 posts
CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m
CVS Health's Aetna to pay $117.7M over Medicare Advantage diagnosis code fraud. Read what this means for CVS stock and managed care enforcement.
Why CVS Caremark’s decision to drop Zepbound could reshape the billion-dollar weight-loss drug war
CVS Caremark faces a lawsuit after dropping Eli Lilly’s Zepbound from coverage. Explore patient, investor, and payer implications in the GLP-1 market battle.
Zydus Lifesciences posts strong Q3 FY25 results with 30% net profit surge
Zydus Lifesciences Limited has reported robust financial performance for the third quarter of fiscal year 2025, driven by…